Capricor Therapeutics GAAP EPS of -$0.53 misses by $0.21

1 month ago 3

Earnings News

Capricor Therapeutics, Inc. press release (NASDAQ:CAPR): Q1 GAAP EPS of -$0.53 misses by $0.21.
Cash, cash equivalents and marketable securities totaled approximately $144.8 million as of March 31, 2025 compared to approximately $151.5 million as of December 31, 2024.
Financial Outlook: The

Recommended For You

More Trending News

Read Entire Article